Company / Cash per Share
FATE THERAPEUTICS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.41
FY2025
5-year range
$0.37 / $1.91
FY2021-FY2025
Trend
+12.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $0.41.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of -20.9%.
Declined from $0.43 to $0.41 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -13.9%
- 5-Year CAGR
- -20.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 12.0% year-over-year.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +12.0% |
| FY2024 | $0.37 | -15.0% |
| FY2023 | $0.43 | -32.8% |
| FY2022 | $0.64 | -66.4% |
| FY2021 | $1.91 | +44.7% |
| FY2020 | $1.32 | -55.2% |
| FY2019 | $2.94 | +74.3% |
| FY2018 | $1.69 | -21.1% |
| FY2017 | $2.14 | -5.1% |
| FY2016 | $2.26 | -14.1% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026